In celebration of American Pharmacists Month, Melissa McGivney, PharmD, FAPhA, FCCP, provides a snapshot of where the profession has come and where it still has to go.
|Articles|September 20, 2007
Community pharmacy groups advocate Medicaid issues to lawmakers
More than 70 pharmacy executives and representatives visited with members of Congress.
Advertisement
More than 70 pharmacy executives and representatives from pharmacy companies across the country visited yesterday with members of Congress to advocate on behalf of community pharmacy. The effort is a collaboration among NACDS, the Food Marketing Institute, and NCPA to address Medicaid access issues, including average manufacturer price (AMP) and implementation of a new tamper-proof prescription paper requirement for Medicaid Rxs.
To go to the Drug Topics homepage,
Advertisement
Related to this article
Pharmacist-backed picks help families manage fever and pain, seasonal allergies, and cough and congestion as kids head back to the classroom.
Sara Hover, RPh, FAARM, explains how these products are putting pharmacists at the center of safety and evidence evaluations one patient at a time.
Independent pharmacies adapt to specialty drugs, biosimilars, cold-chain, and REMS demands.
During American Pharmacists Month, pharmacy teams reflect on their roles and explore ways to enhance patient care.
Lara Zakaria, PharmD, MS, CNS, FMCP, discusses her perspectives regarding the emergence of wearable technology among community pharmacy patients.
Diabetes medication experts focus on practical access and pharmacist counseling considerations for adults on obesity medication.
The oral tablet formulation was approved for adults with weakened immune systems who have not responded to other therapy.
Advertisement
Advertisement
Trending on Drug Topics
1
Pharmacists Improve Access, Safe Use of Obesity Medications
2
FDA Approves New Drug for HSV Lesions in Adults
3
Is Your Independent Pharmacy Ready for New Therapies and Innovations?
4
Q&A: Emerging Compounded Therapies Demand Pharmacist’s Clinical Judgment | NCPA 2026
5